1. Nunn, A.D., Loberg, M.D. and Conley, R.A. (1983) A structure-distribution relationship approach leading to the development of 99mTc mebrofenin: an improved cholescintigraphic agent. J. Nucl. Med., 24, 423–30.
2. Cumming, S.A., Nechvatal, G., Canning, L.R. et al. (1985) Development of 99mTc regional cerebral blood flow agents based upon the propy-leneamine oxime (PnAO). (abstract). Eur. J. Nucl. Med., 11, 107.
3. Jones, A.G., Dronauge, G.F., Davison, A. et al. (1985) Biological distribution and structure function relationships of hexakisisonitrile Tc(l) complexes (abstract). J. Nucl. Med. All Sci., 29, 200.
4. Ketring, A.R., Deutsch, E., Libson, K. et al. (1983) The Noah’s ark experiment. A search for a suitable animal model for evaluation of cationic 99mTc myocardial imaging agents (abstract). J. Nucl Med., 24, 9.
5. Neirinckx, R.D., Canning, L.R., Piper, I.M. et al (1987) 99mTc d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J. Nucl Med., 28, 191–202.